Humulin-70/30 100 IU Vial 10 ml

Description

Humulin 70/30 contains human insulin as the active ingredient, which is used in the treatment of diabetes. A person is usually described as having diabetes if the pancreas is no longer able to secrete enough insulin to control blood sugar (blood sugar). Humulin 70/30 is used for long-term control of blood sugar. It is a premixed suspension of rapid and long-acting insulin. Its action is prolonged by the inclusion of protamine sulfate in the suspension. How to use First, wash your hands. Before you give the injection, clean your skin as instructed. Clean the rubber stopper on the package, do not remove the stopper. Use a clean, sterile syringe and needle to puncture the rubber stopper and withdraw the amount of insulin Humalin 70/30 you need. Your doctor or clinic specialist will tell you how to do this. Do not share your needles and syringes with anyone. Then inject under the skin as you learned. You should not inject directly into a vein. After the injection, leave the needle in the skin for 5 seconds to make sure you get the full dose. You should not rub the area you just injected. Make sure you inject at least 1/2 inch (1 cm) from the place you last injected, and change the places you inject, as you learned. Warnings and precautions Talk to your doctor, pharmacist or nurse before using Humalin 70/30. If your blood sugar levels are well controlled with your current insulin treatment, you may not feel the warning signs when your blood sugar drops too low. These warning signs are listed later in this leaflet. You should take into account the times you eat your meals, how often you exercise and how much you exercise. You should also keep a close eye on your blood sugar levels by testing your blood glucose regularly. A small number of people who experience hypoglycemia (low blood sugar) after switching from animal insulin to human insulin report that early warning symptoms were less pronounced or different. So if you experience hypoglycemia more often or have difficulty recognizing your symptoms, please discuss this with your doctor. If you answer “yes” to any of the following questions, you should tell your diabetes nurse, doctor or pharmacist. Side Effects Possible side effects Generalized allergy is very rare (affecting less than 1 in 10,000 people). Symptoms are as follows: Low blood pressure Rash all over the body Difficulty breathing Wheezing Rapid heartbeat Sweating Storage Information Before first use, keep Humalin 70/30 in the refrigerator (2-8°C) and do not freeze. Keep the “in-use” vial of Humalin 70/30 at room temperature (below 30°C) for a maximum of 28 days. Do not place it near a heat source or in the sun. Drug Interactions Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. The amount of insulin you need may change if you take any of the following medicines: Steroids, Thyroid hormone replacement therapy, Oral antidiabetic drugs (antidiabetic medications), Acetylsalicylic acid (aspirin), Growth hormone, Octreotide, Lanreotide Beta-2 agonists (eg, ritodrine, salbutamol, or terbutaline); Beta blockers; Thiazide medications or some antidepressants (monoamine oxidase inhibitors); danazol; Some angiotensin-converting enzyme inhibitors (eg, captopril, enalapril); or angiotensin II receptor blockers. Ingredients Human insulin, protamine sulfate, metacresol, phenol, glycerin, sodium phosphate dibasic 7H2O, zinc oxide and water for injection. Sodium hydroxide or hydrochloric acid may be used during the manufacturing process to neutralize acidity. Specifications Humalin 70/30 100 IU/mL is a white, cloudy, sterile suspension for injection containing 100 units of insulin per milliliter (100 IU/mL).